Karyopharm announces selinexor data to be presented at the 2022 american society of clinical oncology annual meeting

Newton, mass. , april 27, 2022 /prnewswire/ -- karyopharm therapeutics inc. (nasdaq:kpti), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that four abstracts highlighting selinexor clinical research have been selected for presentation, including one oral presentation, at the upcoming 2022 american society of clinical oncology (asco) annual meeting taking place june 3-7, 2022, in chicago.
KPTI Ratings Summary
KPTI Quant Ranking